Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ability-Chem is a specialized biotechnology company and contract research organization (CRO) headquartered in Suzhou, China, with additional operations in Shanghai. Founded by Dr. Peng Cho Tang, a prominent medicinal chemist and co-inventor of the cancer drug sunitinib, the company focuses on small molecule drug discovery and development. Ability-Chem provides a range of services including medicinal chemistry, custom synthesis, and lead optimization to global pharmaceutical and biotech partners. In addition to its service-based business, the company maintains internal research programs aimed at developing novel therapeutics for oncology and metabolic disorders. The firm leverages its deep expertise in structure-activity relationship (SAR) analysis and complex chemical synthesis to accelerate the delivery of high-quality clinical candidates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ability-Chem.